Search research articles
Contact Us
Filters
Showing results (21-30 of 321) with videos related to
Page
of 33
Sort By:
American Journal of Clinical Oncology
|
April 1, 1995
Multicentric Castleman's disease
J Herrada, F F Cabanillas
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 1, 1995
Polymerase chain reaction monitoring for bcl-2 can be a dependable test under the right conditions
F Cabanillas, M S Lee
Oncology (Williston Park, N.Y.)
|
November 27, 1998
Overview of prognostic factors in non-Hodgkin's lymphoma
D F Moore, F Cabanillas
Leukemia & Lymphoma
|
October 1, 1993
What constitutes a "cure" in lymphoma?
D F Moore, F Cabanillas
Leukemia
|
June 1, 1996
Mantle cell lymphoma: a lymphoproliferative disorder associated with aberrant function of the cell cycle
J Garcia-Conde, F Cabanillas
Seminars in Hematology
|
April 1, 1994
MINE-ESHAP salvage therapy for recurrent and refractory lymphomas
F Cabanillas, M A Rodriguez
Current Opinion in Oncology
|
October 1, 1991
Treatment of non-Hodgkin's lymphoma
J R Diaz-Pavon, F Cabanillas
Hematological Oncology
|
April 1, 1987
Long-term results of treatment of patients with follicular lymphomas
S Kalter, L Holmes, F Cabanillas
Blood
|
November 8, 2001
Interleukin-13 levels in serum from patients with Hodgkin disease and healthy volunteers
P Fiumara, F Cabanillas, A Younes
Hematology/Oncology Clinics of North America
|
October 23, 1997
Long-term follow-up of platinum-based lymphoma salvage regimens. The M.D. Anderson Cancer Center experience
E J Rodriguez-Monge, F Cabanillas
Page
of 33
Search research articles
Search
Showing results (21-30 of 321) with videos related to
Sort By:
Page
of 33
American Journal of Clinical Oncology
|
April 1, 1995
Multicentric Castleman's disease
J Herrada, F F Cabanillas
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 1, 1995
Polymerase chain reaction monitoring for bcl-2 can be a dependable test under the right conditions
F Cabanillas, M S Lee
Oncology (Williston Park, N.Y.)
|
November 27, 1998
Overview of prognostic factors in non-Hodgkin's lymphoma
D F Moore, F Cabanillas
Leukemia & Lymphoma
|
October 1, 1993
What constitutes a "cure" in lymphoma?
D F Moore, F Cabanillas
Leukemia
|
June 1, 1996
Mantle cell lymphoma: a lymphoproliferative disorder associated with aberrant function of the cell cycle
J Garcia-Conde, F Cabanillas
Seminars in Hematology
|
April 1, 1994
MINE-ESHAP salvage therapy for recurrent and refractory lymphomas
F Cabanillas, M A Rodriguez
Current Opinion in Oncology
|
October 1, 1991
Treatment of non-Hodgkin's lymphoma
J R Diaz-Pavon, F Cabanillas
Hematological Oncology
|
April 1, 1987
Long-term results of treatment of patients with follicular lymphomas
S Kalter, L Holmes, F Cabanillas
Blood
|
November 8, 2001
Interleukin-13 levels in serum from patients with Hodgkin disease and healthy volunteers
P Fiumara, F Cabanillas, A Younes
Hematology/Oncology Clinics of North America
|
October 23, 1997
Long-term follow-up of platinum-based lymphoma salvage regimens. The M.D. Anderson Cancer Center experience
E J Rodriguez-Monge, F Cabanillas
Page
of 33